Fort Washington Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Fort Washington Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$295K	Hold	1,300	–	–	﹤0.01%	381
2026 Q1	$224K	Hold	1,300	–	–	﹤0.01%	400
2025 Q4	$259K	Hold	1,300	–	–	﹤0.01%	388
2025 Q3	$203K	Buy	+1,300	New	+$206K	﹤0.01%	410
2025 Q1	–	Sell	-1,300	Closed	-$240K	–	398
2024 Q4	$240K	Hold	1,300	–	–	﹤0.01%	382
2024 Q3	$256K	Hold	1,300	–	–	﹤0.01%	379
2024 Q2	$269K	Buy	1,300 +380	+41%	+$86.1K	﹤0.01%	376
2024 Q1	$249K	Buy	920 +20	+2%	+$4.78K	﹤0.01%	381
2023 Q4	$213K	Buy	+900	New	+$177K	﹤0.01%	384
2022 Q2	–	Sell	-900	Closed	-$256K	–	425
2022 Q1	$256K	Hold	900	–	–	﹤0.01%	479
2021 Q4	$339K	Hold	900	–	–	﹤0.01%	458
2021 Q3	$371K	Hold	900	–	–	﹤0.01%	434
2021 Q2	$333K	Hold	900	–	–	﹤0.01%	444
2021 Q1	$261K	Hold	900	–	–	﹤0.01%	461
2020 Q4	$225K	Sell	900 -900	-50%	-$214K	﹤0.01%	476
2020 Q3	$408K	Hold	1,800	–	–	﹤0.01%	389
2020 Q2	$314K	Hold	1,800	–	–	﹤0.01%	426
2020 Q1	$227K	Buy	1,800 +100	+6%	+$15K	﹤0.01%	403
2019 Q4	$260K	Hold	1,700	–	–	﹤0.01%	455
2019 Q3	$225K	Hold	1,700	–	–	﹤0.01%	476
2019 Q2	$241K	Hold	1,700	–	–	﹤0.01%	478
2019 Q1	$247K	Buy	+1,700	New	+$223K	﹤0.01%	477

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Fort Washington Investment Advisors's CRL Position: Q2 2026 in Review

Fort Washington Investment Advisors held its Charles River Laboratories (CRL) position steady in Q2 2026 at 1,300 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Fort Washington Investment Advisors first reported a position in CRL in Q1 2019 and has held it in 22 quarters since. The position peaked at $408K in Q3 2020. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Fort Washington Investment Advisors held 1,300 shares of Charles River Laboratories worth $295K as of Q2 2026.
Fort Washington Investment Advisors left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #381 holding.
Fort Washington Investment Advisors first reported a position in Charles River Laboratories in Q1 2019 and has held it in 22 quarters since.
Fort Washington Investment Advisors's Charles River Laboratories position peaked at $408K in Q3 2020.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.